Treatment for severe acute respiratory distress syndrome from COVID-19

Lancet Respir Med. 2020 May;8(5):433-434. doi: 10.1016/S2213-2600(20)30127-2. Epub 2020 Mar 20.

Authors

Michael A Matthay¹, J Matthew Aldrich², Jeffrey E Gotts²

Affiliations

¹ Department of Medicine, Department of Anesthesia, The University of California, San Francisco, CA 94158, USA; Cardiovascular Research Institute, The University of California, San Francisco, CA 94158, USA. Electronic address: michael.matthay@ucsf.edu.
² Department of Medicine, Department of Anesthesia, The University of California, San Francisco, CA 94158, USA.

No abstract available

Publication types

Comment

MeSH terms

Betacoronavirus
COVID-19
Communicable Diseases, Emerging*
Coronavirus Infections
Disease Outbreaks
Extracorporeal Membrane Oxygenation*
Humans
Pandemics
Pneumonia, Viral
Respiratory Distress Syndrome*
SARS-CoV-2